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Abstract 
Cost-effectiveness analysis (CEA) is becoming in- 
creasingly popular as society moves toward rationalizing 
health costs. This review describes the applications and 
limitations of the technique. Conceptually simple though 
frequently complicated in application, CEA compares the 
cost of a procedure with its effectiveness, thus he$ing an 
administrator to judge whether the procedure is worth its 
cost. CEA also permits comparison of various intetven- 
tions that result in a similar health outcome. A major 
benefit of CEA is that it forces decision makers to confront 
the tradeoffs implicit in all decisions regarding alternative 
approaches. Limitations of the CEA philosophy and tech- 
nique also have to be understood if it is to be employed 
effectively; it is not an assessment of cost savings, nor is 
it a decision-making technique because it does not incor- 
porate value judgments. A number of potential applica- 
tions to dentistry are described. 
Key Words: cost-effectiveness analysis, economics of 
health care, dentistry, dental public health. 
In the decade of the 1980s, cost containment and cost 
effectiveness have become dominant themes-and often 
misused and abused buzzwords (1)-throughout the 
broad field of health care. The search for efficiency in the 
provision of health care services is motivated by the high 
and rising costs of health care, an activity that currently 
consumes almost twice the share of gross national 
product that it claimed as recently as the mid-1960s. 
Toward the goal of rationalizing the allocation of scarce 
health care resources, health professionals and 
economists increasingly have turned to cost-effective- 
ness analysis (CEA) to assess the efficiency of specific 
health care interventions. Data on health care CEAs, and 
on the closely related technique of cost-benefit analysis 
(CBA), indicate that the growth in interest in these tech- 
niques can be fairly characterized as explosive. For the 
period from 1966 through the end of the 1970s, a col- 
league and I identified approximately 600 professional 
publications relating to CEA and CBA (2). A recent MED- 
LINE search revealed almost 5,000 contributions pertain- 
ing to CEA and CBA from 1966 through early 1989. 
The field of dental public health has demonstrated 
interest in cost containment and cost effectiveness, as 
well. A predecessor to this workshop, held here more 
than a decade ago, examined cost-effectiveness issues 
explicitly (3); a 1980 conference, focusing on the cost of 
dental care, adopted the principle of encouraging dental 
public health professionals and economists to work 
together on issues of dental care efficiency (4). Applica- 
tion of CEA and CBA to dental health more generally is 
found in some 145 publications related directly to this 
subject, identified during the aforementioned MEDLINE 
search. 
At the outset of this ambitious workshop, therefore, it 
seems useful to take a shared, critical look at the techni- 
que that will dominate your attention over the next few 
days. What is cost-effectiveness analysis and what can it 
do (and whatcanitnotdo)?Whatkindsofproblemsdoes 
one encounter in undertaking CEA? How should one 
interpret the findings of CEAs? And what are some 
specific issues and concerns that this group will have to 
address in its attempt to characterize the cost effective- 
ness of a variety of dental public health interventions? 
Nature and Functions of Cost-effectiveness Analysis 
At the outset, it is imperative to emphasize what cost 
effectiveness does not mean: it does not mean cost saving. 
A cost-saving intervention is one that brings in more 
resources than it consumes. A delightful outcome that 
undoubtedly occurs in some instances, cost-saving inter- 
ventions are considerably less common in health care 
than many practitioners of the art want to believe (5). 
Cost effectiveness is something different. It implies a 
comparison of the cost of an intervention with its effec- 
tiveness. In turn, thiscomparison permits an assessment, 
by a decision maker, of whether the health outcome 
derived from an intervention is worth its cost, or it per- 
mits comparison of efficiency across interventions 
producing similar kinds of health outcomes. In essence, 
cost-effectiveness analysis aids a decision maker in de- 
termining how to attain particular desirable outcomes at 
least cost or, conversely, how to take a given budget and 
maximize the desirable outcome achieved through its 
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TABLE 1 
Steps in Cost-effectiveness Analysis 
I. Define problem and objective($ 
2. Identify Alternatives 
3. Describe production relationships 
4. Identify, measure, and value costs 
5. Identify and measure effectiveness 
6. Discount future costs and effectiveness 
7. Address problems of uncertainty 
8. Address issues of equity 
9. Present and interpret findings 
10. Facilitate transition from analysis to 
implementation 
deployment. 
To the uninitiated, the label "cost-effectiveness 
analysis" frequently connotes a highly sophisticated 
analytical technique. While there are numerous CE As 
that are elaborate, sophisticated, computer modeling ex- 
ercises, there are also many simple ,'back-of-the-en- 
velope" CEAs. Illustrative of the latter is the calculation 
that each participant in this workshop performed, most 
likely implicitly, in deciding whether or not to attend. 
The cost of participating is the loss of a couple of days, 
which could have been devoted to other productive ac- 
tivities or to leisure. Each participant had to decide 
whether that cost would be worth the anticipated educa- 
tional or professional benefit. As this experience sug- 
gests, there is nothing inherently complex or confusing 
in cost-effectiveness analysis. Regardless of its level of 
sophistication, every CEA requires the analyst to work 
through the ten basic steps in Table 1. Details on what 
goes in to each of these analytic steps are discussed by 
Warner and Luce (2). 
The potential value of formal CEAs is frequently 
misinterpreted. A common perception is that CEA is a 
decision-making technique, an analytical device that will 
provide ananswer to a policy question. If one adopts this 
perspective, one will find CEA a disappointment, for the 
technique is ill-suited to the task of making decisions. 
Rather, at its best, CEA is useful as a decision-assisting 
technique. In part, the distinction reflects the technical 
limitations that pervade analyses; these are discussed 
below. More fundamentally, the distinction between a 
decision-making and a decision-assisting role for CEA 
reflects the essential fact that policy decisions inevitabIy 
require value judgments, be they political or social, and 
value judgments must be made by human decision 
makers, by politicians, and by bureaucrats. Most of us 
have a visceral negative reaction to the words politicsand 
bureaucracy. But when one contemplates how a society 
should allocate public resources, it is difficult to envision 
a more appropriate, or functional, approach. In this con- 
text, one wants to employ analytical techniques that will 
help to optimize the decision making that occurs within 
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the bureaucratic and political framework. 
Figure 1 lends some insight into the spectrum of views 
of the potential usefulness (or lack thereof) of CEA. On 
the left-hand side of the spectrum are potential negative 
outcomes of analysis, possibilities that warranted more 
attention years ago than they do today. Currently, inter- 
est in CEA ranges from the middle perspective (no im- 
pact) to the right-hand extreme perception of CEA as a 
decision-making technique. The points in between the 
middle and the right-hand end of the spectrum represent 
what I believe CEA can deliver when it is performed, and 
interpreted, optimally. 
How can CEAs assist in decision making? Done well, 
they can indeed be consciousness-raising, as Figure 1 
suggests, and they can be informative about the quantita- 
tive dimensions of problems. CEAs can lend insight into 
the nature of trade-offs and can force decision makers to 
confront those trade-offs openly and honestly. They can 
provide estimates of those dimensions of costs and effec- 
tiveness that are properly quantifiable. Best of all, CEAs 
can provide a framework for discussion of the issues by 
those affected by interventions, and by those who must 
decide whether or not to implement them. 
Problems in CEA 
Most cost-effectiveness analyses are pervaded by com- 
plexities and uncertainties, both conceptual and quan- 
titative. Conceptual issues include, for example, ques- 
tions about what types of costs or benefits should be 
considered in a CEA. What opportunity costs should be 
included in an analysis that are not available through 
assessments of direct expenditures? This is an obvious 
issue for this workshop, given that the meeting or- 
ganizers have only been able to provide estimates of 
direct programmatic expenditures. What are the social 
costs involved in dental public health programs? How 
should analysts deal with the value of patients' time, 
especially given that patients' time is likely to vary sig- 
nificantly among types of dental public health interven- 
tions? (Water fluoridation requires no additional time on 
the part of patients; a mouthrinse program does, how- 
ever.) How about the pain and suffering inflicted in the 
course of an intervention (a cost) or avoided as a result of 
a successful prevention measure (a benefit)? What is it 
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about good dentition that represents a benefit? Why do 
we want good dentition? How do we measure it? While 
we take it for granted that good dentition is desirable, 
what are the real attributes that we are trying to attain? 
In analyzing benefits or effectiveness, there are at least 
five categories or types of measures that may be of inter- 
est. Most prominent among these are personal health 
benefits, such as good dentition. Health care resource 
savings constitute a second prominent benefit of interest; 
these are the dollars that might be saved through an 
intervention. The three remaining categories are other 
economic benefits; other social benefits that might be 
distributional in nature; and intermediate outcomes, 
such as behavioral change believed to be a precursor of 
health status improvement (2). As an example of an 
intermediate outcome, while the ultimate objective of 
flossing is good dental health, an analyst examining the 
cost effectiveness of a flossing educational program 
might measure how many people floss by the end of the 
program or some time after it ends. The true health 
benefit ”better dental health” would beassumed to follow 
in some direct proportion. 
Quantitative complexities in CEA often seem more 
mundane than the conceptual issues, but their resolution 
is of no less importance. In some instances, they reflect 
conceptual issues directly: if an analyst decides, for ex- 
ample, to include the value of patients‘ time as a cost 
variable (a decision regarding a conceptual matter), how 
should that timebe valued (aquantification issue)? While 
there are standard procedures applied to valuing adults’ 
time (typically at the patients‘ hourly wage rates), recent 
analyses have adopted alternative measures (6). In addi- 
tion, the standard solutions are of little utility in trying to 
determine how to value the time of schoolchildren taken 
from their studies to participate in a school-based 
mouthrinse program. 
A common quantitative problem confronting the CEA 
analyst is the selection of a discount rate. This is the rate 
a t  which future years’ costs and effectiveness are dis- 
counted to convert them to estimates of their present 
values. An important aspect of cost-effectiveness 
analysis in general, discounting has particular impor- 
tance for those interventions that have long-term out- 
comes, and hence significant lags in the realization of 
effectiveness (and often costs, as well). A small variation 
in the discount rate can have significant effects onestima- 
tion of cost effectiveness in such circumstances, since 
bothcostsandeffectivenessare subject todiscounting(2). 
An issue influencing both the conceptual and quantita- 
tive dimensions of a CEA is definition of the perspective 
of the analysis. CEAs can be approached from three 
different perspectives. One is the social perspective: what 
is the desirability of an intervention (or the comparative 
desirability of alternative interventions) from a broad 
societal perspective? A second perspective is that of an 
individual who might eitherbeapractitionerorapatient. 
Surely, individuals in these categories will view the 
desirability of an intervention, and its component costs 
and effectiveness, quite differently. The third perspec- 
tive, also involving different assessment of costs and 
effectiveness (their nature as well as measurement), 
would be that of an organization, be it a health care 
delivery organization, an insurance company, a 
governmental agency, or a private business. 
The issue of the value of patients’ time nicely illustrates 
how the basic perspective of an analysis affects the iden- 
tification of categories of costs and benefits and measure- 
ment of them. To practitioners, for example, patients’ 
time is of little direct relevance, and hence is a variable 
that would be omitted from a CEA undertaken from the 
practitioners’ perspective. From a social perspective, by 
contrast, patients’ time may be a significant cost in the 
equation, as it reflects a true social or opportunity cost. 
Similarly, patients’ time would be included in a CEA 
reflecting the patients’ perspective, although in this case 
the value of that time would represent a private cost. 
From an organizational point of view, patients’ time 
might or might not be a relevant cost item, depending on 
the particular interests of the organization in question. 
An insurance company might not care about the value of 
patients’ time; a business, on the other hand, would care 
if interventions were to take place during work time, in 
which case the business would lose productivity; a union 
negotiating health care benefits might care whether or 
not services were received on company time. Note, how- 
ever, that it might value patients‘ (i.e., union members’) 
time differently than would the business. 
Confronted with a sometimes bewildering array of 
approaches to CEA, and in particular an absence of clear 
standards about consistent definition of the components 
of CEAs and of consistent measurement of them, a few 
prominent analysts have begun to call for the develop- 
ment of uniform standards so that cost-effectiveness 
analyses would be directly comparable to one another 
(7). While the objective is commendable, the call for 
consistency seems premature at this time. Attainment of 
a consensus rule or value would be a difficult exercise at 
best, and one that might lead to consistent but errant 
analysis. Furthermore, standardization of analytical 
rules would not accommodate the legitimate differences 
that reflect differences in perspective. (One proposed 
“rule” is that all CEAs be undertaken from a social 
perspective.) 
Interpretation of CEAs raises a series of additional 
questions and problems. Perhaps foremost among these 
is the issue of generalizability. Is a finding in a clinical 
setting generalizable to the community setting? This is 
the standard medical issue of efficacy, or outcome under 
best-practice conditions, vs effectiveness, outcome in 
conventional community care (8). Can the results of a 
small-scale program be extrapolated to a largescale 
operation? Will CEA findings generalize from one time 
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period to another, when the environment or technology 
may have undergone considerable change, or from one 
locale to another with a different institutional setting or 
labor market (2)? 
Finally, in this cursory (and perhaps overly dismal) 
view of problems in CEA, there is a problem that 
transcends CEA per se, but seems to pervade this par- 
ticular analytical endeavor: analyses are often poorly 
done and yet they are accepted quite uncritically by their 
readership. This phenomenon is vividly illustrated by a 
recent survey-based analysis of wellness programs in the 
workplace setting that concluded: "On average the an- 
nual savings [from corporate wellness programs] 
reported was $49.74 per employee.. . .[Tlhe cost-benefit 
ratio . . . is$3.44 saved per dollar of annual operating cost" 
(9). This figure-indeed, the direct quote-has been cited 
in scores of speeches and publications extolling the vir- 
tues of workplace wellness programs. But consider the 
origin of the conclusion: 500 companies were surveyed, 
of which 141 (28%) responded, a response rate typical of 
commercial studies that would be deemed wholly unac- 
ceptable in a scholarly setting because of the likelihood 
of response bias. Of the respondents, 89 companies (63%) 
reported offering wellness programs. Ten companies 
(11% of those offering wellness programs) reported 
having program savings measurements, and three of 
these ten companies (30%) reported their average level of 
savings. Thus, the often quoted benefit-cost ratio of $3.44 
comes from self-reports from three companies out of an 
initial sample of 500. Aside from the rather poor repre- 
sentation, the survey did not assess how these three 
companies derived their savings measures. 
It is imperative to close this discussion of problems in 
CEA by emphasizing that, while common, these difficul- 
ties do not adhere to all CEAs and certainly not to the best 
of the art. Well done, with limitations carefully noted, 
cost-effectiveness analysis can provide a useful quantita- 
tive insight into what it will cost to derive a particular set 
of benefits. More generally, a good analysis, even if it is 
quite imperfect, can provide perspective on a challenging 
decision problem. It may be qualitative perspective, as 
opposed to quantitative perspective, but if it lends insight 
into the nature of the policy decision choice, it can be 
immensely helpful. 
Nature and Interpretation of Findings in a CEA 
The typical cost-effectiveness analysis yields an ag- 
gregated estimate of cost and a single measure of effec- 
tiveness. Analysts typically divide the former by the 
latter to produce a cost-effectiveness ratio. The materials 
distributed for this workshop focus on the development 
of such ratios; that is the essential objective of the meet- 
ing. 
The standard interpretation of cost-effectiveness ratios 
is that they can be used directly to rank programmatic or 
policy alternatives in terms of their relative desirability. 
Unfortunately, this conventional wisdom is incorrect the 
majority of the time, even ignoring the aforementioned 
complexities in defining and measuring costs and effec- 
tiveness. The use of the ratios for ranking purposes is 
valid only if one of two conditions holds: (1) costs are 
identical across the alternatives, so that one is looking for 
the highest level of effectiveness given the same level of 
cost; or (2) effectiveness is the same across the alterna- 
tives, in which case one is seeking the lowest costs to 
attain the given level of effectiveness. 
The limitations of the ratio for ranking purposes, as 
well as the possibilities, are demonstrated in the follow- 
ing example, drawing on the data in Table 2. This table 
presents four hypothetical alternative programs: S, T, U, 
and V. For purposes of this example, we assume that the 
cost figures correctly incorporate all relevant costs, and 
that the effectiveness measure-number of lives saved- 
accurately reflects the major health benefits to be derived 
from the four programs. Thus, we do not confront any of 
the conceptual or analytical problems raised in the 
preceding section. 
Begin by comparing programs S and T. We can make 
a direct comparison between those two because their 
costs are identical, $lOO,OOO. Program T saves more lives 
than does program S. Consequently, T's cost-effective- 
ness ratio is lower than that of S, $8,333 compared with 
$lO,OOO per life saved. Program T thus clearly dominates 
program S, and because S and T have identical costs, the 
cost-effectiveness ratio (here a direct reflection of the 
relative effectiveness of the two programs) is a valid tool 
for ranking the relative desirability of S and T. In a 
precisely analogous fashion, one sees that program V 
dominates program U each has the same cost; V saves 
more lives, and consequently produces a lower cost-ef- 
fectiveness ratio ($13,333 vs $16,667 per life saved). 
Similarly, we can compare programs T and U, because 
they have identical effectiveness at 12 lives saved. Tbeing 
less expensive than U leads to a lower cost-effectiveness 
ratio for T ($8,333 vs $16,667 per life saved). The ratio is 
a valid measure for ranking because the identical effec- 
tiveness measures make the ratio rankings the same as a 
ranking by least cost to achieve the given health outcome. 
TABLE 2 




(No. of Lives Ratio ($/Life 
Program Cost ($1 Saved) Saved) 
S 100,000 10 10,000 
T 100,000 12 8,333 
U 200,000 12 16,667 
V 200,000 15 13,333 
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(Note that U has now been '%eaten" twice, once on cost 
grounds, the other time on effectiveness.) 
Which of S, T, U, and V is the most desirable program? 
The above logic has reduced the comparison problem to 
two options: T and V. The conventional wisdom would 
argue that T is the best alternative because its cost-effec- 
tiveness ratio is lower than that of V ($8,333 vs $13,333 
per life saved). But in this comparison, neither cost nor 
effectiveness is the same for the two groups. If the 
decision makers were restricted to selecting a single pro- 
gram-that is, if they did not have the option of choosing 
two $100,000 programs instead of one $200,000 pro- 
gram-would T be clearly preferable to V? 
The answer would be unequivocally in the affirmative 
if one relied uncritically on the cost-effectiveness ratio. 
But note the implication of doing so: choice of program 
T instead of V means forgoing the saving of three addi- 
tional lives in programV in exchange for saving$100,000. 
Is this a "good deal"? Program V saves the additional 
three lives at a marginal, or extra, cost of $33,333 per life 
saved. Compared with a wide variety of health care 
interventions, this price for life saving is a veritable bar- 
gain(10). As such, the simplecostsffectivenessratiodoes 
not provide a "correct" ranking for programs T and V. 
The issue here is one of a value judgment, one that 
must be made by a political or bureaucratic decision 
maker: is the gain of three more lives saved worth the 
extra expenditure of $lOO,OOO? This question does not 
lend itself to a neat, mathematical, objective answer. The 
example illustrates both the utility of cost-effectiveness 
ra t iosthey permitted us to narrow the choice set from 
four to two option-nd the futility of relying exclusive- 
ly and uncritically on this single summary number. (In- 
cidentally, note that with the option of choosing two 
programs, S plus Tcertainly would dominate V, since the 
former would save seven more lives collectively 110 + 121 
than would the latter [15]. Still better would be replicat- 
ing program T, since two "units" of T would produce 24 
lives saved for the $200,000. Often, however, an agency 
does not have the flexibility to pursue more than one 
programmatic strategy.) 
The cost-effectiveness ratio has ano ther implicit limita- 
tion, not illustrated by the preceding example: it treats 
the choice problem as if there is only one nonmonetary 
outcome worthy of attention. Often this may be the case. 
A health program may have a single dominant health 
outcome; water fluoridation may be a good example in 
this context. Alternatively, analysts may be able to 
develop an index that captures multiple outcomes in a 
useful manner. In dental public health, the DMFT 
measure comes to mind; more generally in health care, a 
variety of health status indices have been developed, 
including the most well-known acronym in the field, 
QALYs, or the index of quality-adjusted life-years (2). 
Often, however, real-life health programs may not 
produce easily indexed outcomes. Commonly, programs 
TABLE 3 
Arraying Multiple Effectiveness Measures in a CEA 
Saved 
Years of Days of Days of 
Program Costs ($1 Life Morbidity Disability 
W 100,000 5 25 30 
X 100,000 5 20 25 
Y 100,000 4 400 35 
Z 200,000 7 60 80 
may have multipleoutcomes that do not lend themselves 
neatly to being measured, weighted, and summed into a 
single index. In such instances, an alternative approach 
might be to array costs and outcomes in a matrix form. 
This approach is illustrated inTable 3. Programs W, X, Y, 
and Z are arrayed with their costs and three types of 
effectiveness outcome measures: years of life saved, days 
of morbidity avoided, and days of disability avoided. No 
single cost-effectiveness ratio provides a "bottom line" 
valuation of the alternative programs. Nevertheless, the 
matrix summarizes the findings of the CEA and provides 
considerable useful information to the decision makers 
who will have to choose among the alternatives. 
Note that the data in Table 3 permit some objective 
narrowing of the choice problem. Specifically, program 
W clearly dominates program X, since it has the same 
costs and the same or more effectiveness in each of the 
three outcome categories. Beyond this comparison, how- 
ever, there is no objective domination among W, Y, and 
Z. They all have different attributes; each entails different 
trade-offs. By arraying the outcomes in this fashion, how- 
ever, the analyst makes these trade-offs explicit and 
thereby informs the decision process. 
This matrix approach to concluding a cost-effective- 
ness analysis has been applied very infrequently. Ob- 
viously, it is not as satisfying as a single definitive con- 
clusion. Still, it is informative, it can be more comprehen- 
sive, and it can be quite useful. This is an approach that 
one hopes will gain acceptance in the community of 
health services research. 
Dealing with the Ambiguities in CEA 
The uncertainties and complexities found in most 
CEAs beg attention. Fortunately, there are analytical 
techniques available to assist in grappling with such 
problems, and there are reminders of the true potential 
of CEA that can put these problems in perspective. 
Notable among these are the following: 
1. Liberal use of sensitivity analysis can determine the 
importance of uncertainties, data problems, and the like. 
While the term "sensitivity analysis" encompasses 
several specific techniques (21, all of them share the prin- 
cipal notion: vary the uncertain element and find out 
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whether or not it affects the basic qualitative finding of 
an analysis. Through sensitivity analysis, analysts can 
learn that a nagging uncertainty is not important, that is, 
it may not affect the study’s basic conclusions. Alterna- 
tively, sensitivity analysis can tell an analyst that a par- 
ticular uncertainty is critical to the conclusion, and there- 
by recommend caution in interpretation of findings. The 
latter outcome also implicitly suggests an agenda for 
further research to narrow the important uncertainties. 
2. Of great importance is a constant reminder, to 
analyst and decision-making client alike, that CEA‘s 
legitimate role is to contribute information and perspec- 
tive to a decision problem that is inherently subjective. 
As such, the limitations of CEA are appreciated in con- 
text, and the utility of analysis perhaps better under- 
stood. 
3. Finally, both analysts and decision makers need to 
recognize that progress is being made in refining the 
technical art of CEA. The methodology of analysis has 
witnessed several improvements over the past decade 
and more can be anticipated in the future. We need not 
await such improvements to improve the practice of CEA 
today, however. Efforts need to be made to get analysts 
to incorporate existing state-of-the-art methodology into 
their work. Altogether too many CEAs are weak because 
of poor application of good techniques, rather than the 
reverse. 
In his foreword to our textbook on cost-benefit and 
cost-effectiveness analysis in health care (2), health 
economist Victor Fuchs concluded that we were unduly 
cynical about the potential of CBA and CEA to find useful 
niches in the world of health care policy decision making. 
In less than a decade since the book’s publication, these 
techniques have found more application in the health 
policy forum than we anticipated. As such, we find that 
Fuchs‘ admonition to our readers bears emphasis: 
cynicism reflecting the limitations of CEA should be 
balanced with optimism about the contribution analysis 
can make to hard policy choice problems. 
CEA and this Workshop: Specific Thoughts 
Given the focused objective of this workshop, it may 
be useful to conclude with some observations directly 
related to the task that lies ahead. Some are general in 
nature, others quite specific to challenges participants 
will confront head on. First and perhaps foremost, it is 
essential that the workshop not get bogged down in the 
esoterica of the analysis and in particular in the imperfec- 
tions of the data that have been provided. Participants 
will have to remain goal oriented, focused on the bigger 
picture the workshop ultimately intends to address. As 
such, individual groups should work through the deriva- 
tion of the cost-effectiveness data and then, afterward, 
see how comfortable group members feel with the 
results. The alternative is to worry about them before 
they are derived, an approach that will almost certainly 
fail to produce costeffectiveness estimates. Indeed, one 
test of the quality of estimates will be the consistency of 
findings across groups. While there are good reasons to 
expect some differences, certain consistencies should 
emerge if the basic task, and the workshop approach to 
it, are sensible. This conclusion will not even be testable 
if all groups do not produce the assigned ratios. 
Specific limitations of data and analysis deserving of 
attention during the course of the workshop include the 
following: 
I. Only direct program costs have been provided to 
workshop participants. This limitation relates in part to 
the issue of the perspective of the analysis, discussed 
below. 
2.Thedataonprogramcostsarelikely tobesignificant- 
ly flawed. This reflects both the exigencies of data collec- 
tion from numerous busy dental health administrators 
and the fact that even perfect budgetary data need not 
accurately reflect true program costs (2). 
3. Are the effectiveness data provided for this 
workshop true estimates of effectiveness, reflecting out- 
comes in conventional practice, or are they really es- 
timates of efficacy, estimating the best that can be 
achieved, under optimal circumstances (B)? Effective- 
ness, rather than efficacy, is what is desired for the pur- 
poses of this workshop. The next speakers can address 
this issue with considerable expertise. 
4. Effectivenessdata pertaining to interventions for the 
elderly are particularly difficult to find. How will the 
workshop deal with this challenge? 
5. There are going to be differences in economies of 
scale across the programs. Specifically, water fluorida- 
tion likely exhibits significant economies of scale, as is 
suggested by the data provided. The alternatives that 
involve treatments for individual patients or clients like- 
ly will exhibit something approximating constant returns 
to scale. Workshop groups will have to struggle with how 
to deal with this phenomenon when the objective is to 
produce single measures of programs’ cost effectiveness 
and rankings of alternatives. 
As noted earlier, frequent use of sensitivity analysis is 
recommended whenever cost or effectiveness estimates 
vary substantially. For an issue such as the effectiveness 
of treatments for the elderly, for which data are par- 
ticularly scarce, break-even analysis may prove to be 
particularly useful (2). 
One major test of the sensitivity of findings relates to 
different groups’ ordinal rankings of program alterna- 
tives. Even if specific cost estimates differ across the 
groups, the relative rankings of program alternatives by 
cost-effectiveness ratios may not. If this outcome is 
achieved, the group should feel quite confident about, 
and satisfied with, the essential findings of the meeting. 
Note, however, that the lack of consistency in rankings 
need not indicate that the exercise has failed. 
The group as a whole needs to address the issue of the 
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perspective of analysis at the outset of the workshop. 
While most participants might desire to adopt a social 
perspective, pragmatic considerations, including data 
availability, may force a narrower public health agency 
budget perspective. This is not necessarily undesirable; 
however, the workshop would benefit from explicit dis- 
cussion about this issue prior to initiating work on 
specific calculations. 
In contemplating the various interventions, par- 
ticipants must be cognizant of the possibility that the cost 
effectiveness of a procedure will vary depending on the 
availability of other procedures. For example, in a com- 
munity with a fluoridated water supply and good brush- 
ing habits, a mouthrinse program likely would have a 
relatively low yield, and hence a high cost-effectiveness 
ratio. In a community lacking fluoridated water, and in 
which good brushing practices may be less common, a 
mouthrinse program would be expected to have greater 
effectiveness, and hence better cost effectiveness. This 
observation leads to two conclusions: (1) cost-effective- 
ness ratios are often situation-specific. Analysts must 
address this in attempts to produce meaningful 
generalizable results; and (2) estimates of cost effective- 
ness of this sort provide only partial insight into the 
desirability of an intervention from the perspective of an 
individual community. It is possible to imagine, for ex- 
ample, a situation in which the residents of a poor com- 
munity would find that it would cost them less using a 
mouthrinse program to reduce caries incidence than it 
would a more affluent community, and yet the people in 
that affluent community would want the program, while 
the people in the poorer community would not. This 
seemingly anomalous result would reflect differences in 
the communities’ demands for the service. The people in 
the more affluent community might value good dentition 
more than the people in the poorer community. The 
implication is that the generation of cost-effectiveness 
ratios does not, in itself, provide complete information 
for the determination of the optimal allocation of dental 
health care resources. Cost-effectiveness information 
must be married with community-specific knowledge of 
demand. 
Finally, in struggling with the data imperfections and 
problems, workshop participants must recognize that 
one of the purposes of going through this exercise is to 
determine how much can be learned from it. In other 
words, the outcome of this meeting is not simply the 
bottom-line numbers, but rather determination of what 
a process like this can accomplish. Given the unique 
structure of the workshop, the success of the process itself 
ultimately may prove as important as the explicit cost-ef- 
fectiveness findings. Either way, the assignment is a chal- 
lengingeone, with all the difficulty and interest that the 
word connotes. 
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